作者: Zhi Geng , Chao Ye , Ying Tong , Feng Zhang , Ye-Bo Zhou
DOI: 10.1152/AJPHEART.00449.2019
关键词: Antagonist 、 Internal medicine 、 Vasopressin 、 Microinjection 、 Medicine 、 Blood pressure 、 Sympathetic nerve activity 、 Endocrinology
摘要: We demonstrated that PVN microinjection of ELA-21 increases sympathetic nerve activity and blood pressure, which can be abolished by pretreatment APJ antagonist. This is the first demonstration ...